Generic placeholder image

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Editorial

HLA-B27 is a Risk Factor for Rheumatoid Arthritis: Suggestion for an Evidence-based Update

Author(s): Seyyed Amir Yasin Ahmadi, Reza Mohammadrezaei-Khorramabadi, Saber Abbaszadeh, Jafar Rezaian and Farhad Shahsavar*

Volume 17, Issue 1, 2020

Page: [7 - 10] Pages: 4

DOI: 10.2174/1875692117666190408113012

Abstract

Previously, the association of human leukocyte antigen (HLA)-B27 with ankylosing spondylitis has been investigated as original and meta-analysis studies. However, the association of HLA-B27 with rheumatoid arthritis is not currently investigated as a meta-analysis. Hence, in this letter, a brief meta-analysis on this association will be performed. Although there were some studies on the association of RA and HLA-B27, however, there was not a pooled odds ratio reported in textbooks. Based on this brief metaanalysis, number 2.687 can be reported as the odds ratio of this association. It shows that this association is neither sensitive nor specific, but can be an idea for pharmacogenomics and personalized medicine as a potential risk factor. Such other associations should be reported numerically and updated in textbooks.

Keywords: HLA-B27, rheumatoid arthritis, meta-analysis, personalized medicine, human leukocyte antigen, immunogenic peptides.

[1]
Ma X, Xu S. TNF inhibitor therapy for rheumatoid arthritis. Biomed Rep 2013; 1(2): 177-84.
[http://dx.doi.org/10.3892/br.2012.42]
[2]
Stolt M, Suhonen R, Leino-Kilpi H. Foot health in patients with rheumatoid arthritis—a scoping review. Rheumatol Int 2017; 37(9): 1413-22.
[http://dx.doi.org/10.1007/s00296-017-3699-0] [PMID: 28324133]
[3]
Venuturupalli S. Immune mechanisms and novel targets in rheumatoid arthritis. Immunol Allergy Clin 2017; 37(2): 301-13.
[http://dx.doi.org/10.1016/j.iac.2017.01.002] [PMID: 28366478]
[4]
Koziel J, Mydel P, Potempa J. The link between periodontal disease and rheumatoid arthritis: An updated review. Curr Rheumatol Rep 2014; 16(3): 408.
[http://dx.doi.org/10.1007/s11926-014-0408-9] [PMID: 24458478] [PMCID: PMC3930831]
[5]
Shahsavar F, Varzi A-M, Ahmadi SAY. A genomic study on distribution of human leukocyte antigen (HLA)-A and HLA-B alleles in Lak population of Iran. Genom Data 2017; 11: 3-6.
[http://dx.doi.org/10.1016/j.gdata.2016.11.012] [PMID: 27900264]
[6]
Khan MA. Polymorphism of HLA-B27: 105 subtypes currently known. Curr Rheumatol Rep 2013; 15(10): 362.
[http://dx.doi.org/10.1007/s11926-013-0362-y] [PMID: 23990399]
[7]
Bowness P. HLA-B27. Annu Rev Immunol 2015; 33: 29-4.
[http://dx.doi.org/10.1146/annurev-immunol-032414-112110]
[8]
Sibley CH. Autoinflammation and HLA-B27: Beyond antigen presentation. Ocul Immunol Inflamm 2016; 24(4): 460-9.
[http://dx.doi.org/10.1080/09273948.2016.1175641] [PMID: 27229619]
[9]
Sieper J, Braun J, Dougados M, Baeten D. Axial spondyloarthritis. Nat Rev Dis Primers 2015; 1: 15013.
[http://dx.doi.org/10.1038/nrdp.2015.13]
[10]
Anbari K, Ahmadi SAY. The software comprehensive meta-analysis needs to be upgraded further: Letter to the editors. Epidemiol Biostat Public Health 2017; 14(2) e12522
[http://dx.doi.org/10.2427/12522]
[11]
Khan MA, Wolfe F, Kleinheksel SM, Molta C. HLA DR4 and B27 antigens in familial and sporadic rheumatoid arthritis. Scand J Rheumatol 1987; 16(6): 433-6.
[http://dx.doi.org/10.3109/03009748709165415]
[12]
Paimela L, Leirisalo-Repo M, Helve T, Koskimies S. The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritis. Scand J Rheumatol 1993; 22(5): 220-4.
[http://dx.doi.org/10.3109/03009749309095126]
[13]
Pasternack A, Tiilikainen A. HLA-B27 in rheumatoid arthritis and amyloidosis. Tissue Antigens 1977; 9(2): 80-9.
[http://dx.doi.org/10.1111/j.1399-0039.1977.tb01086.x]
[14]
Yazici H, Schreuder I, Yurdakul S, Ozbakir F. HLA-B27 in Turkish patients with rheumatoid arthritis. Ann Rheum Dis 1987; 46(9): 718.
[http://dx.doi.org/10.1136/ard.46.9.718]

© 2024 Bentham Science Publishers | Privacy Policy